Migraine Drugs Market Size, Share & Trends Report

Migraine Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Triptans, CGRP-based Therapies, Ditans, Neurotoxins, NSAIDs), By Treatment, By Route Of Administration, And Segment Forecasts, 2018 - 2025

Report ID: GVR-2-68038-559-5
Number of Pages: 98
Format: Electronic (PDF)

Historical Range:
Industry: Healthcare

Market Segmentation

Migraine Drugs Treatment Outlook (Revenue, USD Million, 2017 - 2025)
- Acute Treatment
- Preventive Treatment
Migraine Drugs Therapeutic Class Outlook (Revenue, USD Million, 2017 - 2025)
- Triptans
- Acetylcholine Inhibitors/ neurotoxins
- Ergot Alkaloids
- NSAIDs
- Ditans
- CGRP Small molecule antagonists
- CGRP monoclonal antibodies
- Others
Migraine Drugs Route of Administration Outlook (Revenue, USD Million, 2017 - 2025)
- Oral
- Injectables
- Others
Migraine Drugs Country Outlook (Revenue, USD Million, 2017 - 2025)
- The U.S.
  - The U.S. Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - The U.S. Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - The U.S. Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others
- The U.K.
  - The U.K. Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - The U.K. Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - The U.K. Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others
- Japan
  - Japan Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - Japan Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - Japan Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others
- Germany
  - Germany Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - Germany Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - Germany Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others
- France
  - France Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - France Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - France Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others
- Italy
  - Italy Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - Italy Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - Italy Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others
- Spain
  - Spain Migraine Drugs Market, by Treatment
    - Acute Treatment
    - Preventive Treatment
  - Spain Migraine Drugs Market, by Therapeutic Class
    - Triptans
    - Acetylcholine Inhibitors/ neurotoxins
    - Ergot Alkaloids
    - NSAIDs
    - Ditans
    - CGRP Small molecule antagonists
    - CGRP monoclonal antibodies
    - Others
  - Spain Migraine Drugs Market, by Route of Administration
    - Oral
    - Injectables
    - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2017 to 2025
Market estimates and forecast for product segments up to 2025
Regional market size and forecast for product segments up to 2025
Market estimates and forecast for application segments up to 2025
Regional market size and forecast for application segments up to 2025
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.